申请人:Xue Chu-Biao
公开号:US20100119503A1
公开(公告)日:2010-05-13
The present invention is directed to compounds of Formula I:
which are modulators of chemokine receptors. The compounds of the invention, and compositions thereof, are useful in the treatment of diseases related to chemokine receptor expression and/or activity.
本发明涉及式I的化合物:它们是趋化因子受体的调节剂。本发明的化合物及其组合物在治疗与趋化因子受体表达和/或活性有关的疾病方面是有用的。